Current evidence indicates that inflammatory mediators play a pivotal role in CSOM pathogenesis, with markedly elevated levels of interleukin (IL)−6 and IL-8 in patients with CSOM and notably higher IL-1α levels in those with cholesteatoma involvement4. The gene discussed is IL6; the disease is chronic purulent otitis media.